366 related articles for article (PubMed ID: 21979592)
21. [Malignant transformation of ovarian endometriosis: a clinicopathologic analysis of 49 cases].
Shen YM; Wu XL; Xu L; Huang Q; Yu N; Yao XY; Xie YP
Ai Zheng; 2008 Oct; 27(10):1106-10. PubMed ID: 18851793
[TBL] [Abstract][Full Text] [Related]
22. Epithelial metaplastic changes in ovarian endometriosis.
Fukunaga M; Ushigome S
Mod Pathol; 1998 Aug; 11(8):784-8. PubMed ID: 9720509
[TBL] [Abstract][Full Text] [Related]
23. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
[TBL] [Abstract][Full Text] [Related]
24. Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes.
Sekizawa A; Amemiya S; Otsuka J; Saito H; Farina A; Okai T; Tachikawa T
Med Electron Microsc; 2004 Jun; 37(2):97-100. PubMed ID: 15221651
[TBL] [Abstract][Full Text] [Related]
25. [Ovarian cancer and endometriosis].
Spaczyński M; Kedzia W
Ginekol Pol; 2001 May; 72(5):268-72. PubMed ID: 11526755
[TBL] [Abstract][Full Text] [Related]
26. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
[TBL] [Abstract][Full Text] [Related]
27. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
28. [Morphology and histogenesis of ovarian endometriosis as potential precancerous condition].
Kolosov AE
Vopr Onkol; 1977; 23(3):23-31. PubMed ID: 898792
[TBL] [Abstract][Full Text] [Related]
29. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
Kurman RJ; Vang R; Junge J; Hannibal CG; Kjaer SK; Shih IeM
Am J Surg Pathol; 2011 Nov; 35(11):1605-14. PubMed ID: 21997682
[TBL] [Abstract][Full Text] [Related]
30. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis.
Fuseya C; Horiuchi A; Hayashi A; Suzuki A; Miyamoto T; Hayashi T; Shiozawa T
Hum Pathol; 2012 Nov; 43(11):1964-72. PubMed ID: 22626277
[TBL] [Abstract][Full Text] [Related]
31. Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors.
Yamamoto S; Tsuda H; Takano M; Kita T; Kudoh K; Furuya K; Tamai S; Matsubara O
Mod Pathol; 2008 Feb; 21(2):115-24. PubMed ID: 18084257
[TBL] [Abstract][Full Text] [Related]
32. Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis.
Kobayashi H
Int J Clin Oncol; 2009 Oct; 14(5):378-82. PubMed ID: 19856043
[TBL] [Abstract][Full Text] [Related]
33. Endometriosis-associated Ovarian Cancers.
Anglesio MS; Yong PJ
Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
[TBL] [Abstract][Full Text] [Related]
34. Endometrioid adenocarcinoma of the ovary arising in atypical endometriosis.
Terada T
Int J Clin Exp Pathol; 2012; 5(9):924-7. PubMed ID: 23119109
[TBL] [Abstract][Full Text] [Related]
35. A Systematic Review of Atypical Endometriosis-Associated Biomarkers.
Bartiromo L; Schimberni M; Villanacci R; Mangili G; Ferrari S; Ottolina J; Salmeri N; Dolci C; Tandoi I; Candiani M
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457244
[TBL] [Abstract][Full Text] [Related]
36. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer.
Siufi Neto J; Kho RM; Siufi DF; Baracat EC; Anderson KS; Abrão MS
J Minim Invasive Gynecol; 2014; 21(1):55-63. PubMed ID: 23962574
[TBL] [Abstract][Full Text] [Related]
37. Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer.
Ñiguez Sevilla I; Machado Linde F; Marín Sánchez MDP; Arense JJ; Torroba A; Nieto Díaz A; Sánchez Ferrer ML
J Gynecol Oncol; 2019 Jul; 30(4):e63. PubMed ID: 31074246
[TBL] [Abstract][Full Text] [Related]
38. Ovarian atypical endometriosis: its close association with malignant epithelial tumours.
Fukunaga M; Nomura K; Ishikawa E; Ushigome S
Histopathology; 1997 Mar; 30(3):249-55. PubMed ID: 9088954
[TBL] [Abstract][Full Text] [Related]
39. [Is endometriosis a precancerous lesion? Perspectives and clinical implications].
Chene G; Caloone J; Moret S; Le Bail-Carval K; Chabert P; Beaufils E; Mellier G; Lamblin G
Gynecol Obstet Fertil; 2016 Feb; 44(2):106-12. PubMed ID: 26850282
[TBL] [Abstract][Full Text] [Related]
40. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.
Kato N; Sasou S; Motoyama T
Mod Pathol; 2006 Jan; 19(1):83-9. PubMed ID: 16258507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]